Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pericapsular Nerve Group Block With 20 ml 0.2% Ropivacaine vs 10ml 0.2% Ropivacaine and Dexamethasone in Total Hip Arthroplasty: A Randomized Controlled Trial

NCT06470334 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.

NCT NCT06470334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pericapsular Nerve Group Block With 20 ml 0.2% Ropivacaine vs 10ml 0.2% Ropivacaine and Dexamethasone in Total Hip Arthroplasty: A Randomized Controlled Trial
Lead sponsor
Poznan University of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
November 7, 2024
Completion date
April 30, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthritis, hip osteoarthritis, hip pain chronic